Nonetheless, inhibitors of cholinesterases (AChE, BChE) have shown promise and compounds like donepezil, galantamine, rivastigmine and tacrine have been clinically approved for conditions associated with cognitive decline (Hasselmo, 2006; Takada-Takatori et al., 2006). This evidence concerns the gene ACHE and Mental deterioration.